Vincent Chandan Noel, Cowie Jonathan, Mooteeram Justin, Sugathan Hari
Trauma and Orthopaedics, Manchester Royal Infirmary, Manchester, GBR.
Orthopaedics and Trauma, Stepping Hill Hospital, Manchester, GBR.
Cureus. 2024 Nov 30;16(11):e74814. doi: 10.7759/cureus.74814. eCollection 2024 Nov.
Osteoarthritis (OA) of the foot and ankle is prevalent and often debilitating, necessitating effective treatment options. This study evaluates the analgesic efficacy of corticosteroid injections in individual foot and ankle joints. Stepping Hill Hospital conducted a retrospective audit of 166 patients who received guided corticosteroid injections. We assessed pain relief using a questionnaire to obtain numerical pain scores before and after the injections. Of the 166 patients evaluated, 51% (85) reported complete pain relief and 32% (53) reported partial relief following the injections, with a significant mean pain score reduction from 8.45 (pre-injection) to 3.42 (post-injection) (p<0.05). A total of 83 patients (47.6%) sought re-injection, which also provided significant pain relief, although slightly less effective than the first injection (pain scores: 3.42 (pre-injection) vs. 4.90 (post-injection), p<0.05). Patient satisfaction was 83% overall, with the highest satisfaction at tarsometatarsal joint injections (95%). Corticosteroid injections for foot and ankle OA demonstrate significant analgesic benefits with high patient satisfaction. While first injections were most effective, re-injections remain a viable option, particularly for patients postponing surgery. These results support corticosteroid injections as an essential component of OA management in foot and ankle conditions.
足踝骨关节炎(OA)很常见,且常常使人虚弱,因此需要有效的治疗方案。本研究评估了皮质类固醇注射对单个足踝关节的镇痛效果。斯泰平希尔医院对166例接受引导下皮质类固醇注射的患者进行了回顾性审计。我们通过问卷调查评估注射前后的疼痛缓解情况,以获得数字疼痛评分。在评估的166例患者中,51%(85例)报告注射后疼痛完全缓解,32%(53例)报告部分缓解,注射后平均疼痛评分从8.45(注射前)显著降至3.42(注射后)(p<0.05)。共有83例患者(47.6%)寻求再次注射,再次注射也提供了显著的疼痛缓解,尽管效果略逊于首次注射(疼痛评分:注射前3.42 vs.注射后4.90,p<0.05)。总体患者满意度为83%,跗跖关节注射的满意度最高(95%)。皮质类固醇注射治疗足踝OA显示出显著的镇痛效果,患者满意度高。虽然首次注射效果最佳,但再次注射仍是一个可行的选择,特别是对于推迟手术的患者。这些结果支持皮质类固醇注射作为足踝疾病OA管理的重要组成部分。